These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17144995)

  • 1. [Should Angiotensin-converting enzyme inhibitors be continued over the long term in patients whose left ventricular ejection fraction normalizes after an episode of acute myocarditis?].
    Anguita-Sánchez M; Castillo-Domínguez JC; Mesa-Rubio D; Ruiz-Ortiz M; López-Granados A; Suárez de Lezo J
    Rev Esp Cardiol; 2006 Nov; 59(11):1199-201. PubMed ID: 17144995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term clinical course of acute myocarditis. Prospective study of a series of 99 patients (1987-1995)].
    Torres F; Anguita M; Giménez D; Mesa D; Tejero I; Franco M; Benítez F; Amat M; Vallés F
    Rev Esp Cardiol; 1996 Oct; 49(10):723-31. PubMed ID: 9036474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.
    Fu M; Zhou J; Sun A; Zhang S; Zhang C; Zou Y; Fu M; Ge J
    Int J Cardiol; 2012 Feb; 155(1):33-8. PubMed ID: 21481482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G; Serafini O; Caporale R; Guzzo D; Plastina F
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and four-year outcomes of patients in the Rhode Island Takotsubo Cardiomyopathy Registry.
    Regnante RA; Zuzek RW; Weinsier SB; Latif SR; Linsky RA; Ahmed HN; Sadiq I
    Am J Cardiol; 2009 Apr; 103(7):1015-9. PubMed ID: 19327433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration].
    Komatsu T; Nakamura S; Suzuki O; Horiuchi D; Owada S; Kameda K; Tomita H; Oikawa K; Abe N; Okumura K
    J Cardiol; 2003 Feb; 41(2):73-80. PubMed ID: 12649925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
    Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
    J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
    Bart BA; Ertl G; Held P; Kuch J; Maggioni AP; McMurray J; Michelson EL; Rouleau JL; Warner Stevenson L; Swedberg K; Young JB; Yusuf S; Sellers MA; Granger CB; Califf RM; Pfeffer MA
    Eur Heart J; 1999 Aug; 20(16):1182-90. PubMed ID: 10448027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates.
    Gagliardi MG; Bevilacqua M; Squitieri C; Boldrini R; Di Julio DP; Marcelletti C
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S224-9. PubMed ID: 8312340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.
    Mason JW; O'Connell JB; Herskowitz A; Rose NR; McManus BM; Billingham ME; Moon TE
    N Engl J Med; 1995 Aug; 333(5):269-75. PubMed ID: 7596370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.